Clinical Trial Update: Fluoxetine in KCNC1-related Disorder [NA]

View source ↗

Summary

A clinical trial evaluating fluoxetine for KCNC1-related disorder has completed. The status of the study is listed as Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kcnc1-related Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Holland Bloorview Kids Rehabilitation Hospital | Conditions: KCNC1 Related Disorder, Genetic Disease | NA | Status: COMPLETED